Paclitaxel Articles
sNDA filed for Taxol plus Herceptin
24 June 1999
US advisory committee OKs Alza's Doxil
10 June 1999
Ivax bids for rest of Czech firm Galena
21 May 1999
US patent for Cytoclonal
29 April 1999
-Genta's G3139 reduces Bcl-2 protein levels
22 April 1999
PG-TXL to enter trials as radiosensitizer
20 April 1999
Alza files sNDA for Doxil
20 April 1999
Enzon applies to test Prothecan in USA
6 April 1999
US NCI trial Celgene's Thalomid in NSCL cancer
29 March 1999
Paxene cleared for KS in Czech Republic
29 March 1999
P&U licenses NeoPharm drugs in $65M deal
25 February 1999
Paxene recommended for approval in EU
2 February 1999
Angiotech acquires license for use of paclitaxel in Alzheimer's
26 January 1999
Angiotech Starts Second Topical Paclitaxel Trial
17 December 1998
Xenova Begins XR9576 Phase II Trials
17 December 1998
Vertex MDR Inhibitor Shows Further Promise
16 December 1998
MGI 114 For Ovarian Cancer
2 December 1998
Lachema In Paclitaxel Pact With Xechem
1 December 1998
Cell Therapeutics Tests CT-2584 In Prostate Cancer
25 November 1998
Roche's Xeloda Has Fewer Side Effects
6 November 1998
In Biotech Trust's Achievements In Fiscal 1997/98
3 November 1998
B-MS To Acquire Korean Pharma Firm
28 October 1998
Healthy Third-Quarter Growth For US Drug Majors
22 October 1998
France approves Bristol-Myers Squibb's Taxol for NSCLC
15 October 1998
Herceptin Due For October Launch In The USA
1 October 1998
Hungarian Funding For Paclitaxel Products
28 September 1998
Novopharm Biotech Files For Generic Taxol
17 September 1998
Herceptin Heads Cancer Drugs Backed In USA
10 September 1998
IVAX Wins In B-MS And 3M Patent Cases
28 August 1998
SuperGen File ANDA For Paclitaxel With FDA.
20 August 1998
IVAX, Immunex File For Generic Taxol In USA
18 August 1998
CTI Licenses New Form Of Paclitaxel
22 July 1998
Sanofi's Eloxatin Gearing Up For Global Roll-Out
30 June 1998
Angiotech To Study Paclitaxel In Arthritis
18 June 1998
BTG Offers Taxol Analogs For Licensing
15 June 1998
Cancer Market Growth Forecasts To 2010
15 June 1998
Expanded Use Of R-PR's Taxotere Backed
4 June 1998
IVAX Restructuring, Changing Name
27 May 1998
Taxol, Platinum "Optimal" For Ovarian Cancer
27 May 1998
New York Stock Comment
21 May 1998
Herceptin Data Live Up To Expectations
20 May 1998
Agouron Starts Pivotal Trials Of AG3340
7 May 1998
US Bill Would Make Firms Bid For NIH CRADAs
6 May 1998
Hungary To Pay For Breast Cancer Drugs
5 May 1998
Dutch Court Upholds B-MS Taxol Exclusivity
27 April 1998
US Quarterly Financial Results Round-Up
23 April 1998
Collaborations And Licensing News In Brief
26 March 1998
Xeloda NDA Backed By FDA Advisory Panel
20 March 1998
Continued Roll-Out For NaPro's Paclitaxel
16 March 1998
IL-2 In Ovarian Cancer
19 February 1998
Israel Adopts Dutch Drug Import Pricing System
13 February 1998
High Hopes For New Products At Rhone-Poulenc
5 February 1998
Strong Growth For US Drug Firms In 1997
28 January 1998
Medeva Bladder Cancer Drug Filed In USA
15 January 1998
Israel OKs Extra Funding For New Drug Therapies
12 January 1998
Generic Taxol Gets Tentative US Approval
2 January 1998
Genentech Progress With Breast Cancer Antibody
29 December 1998
NeoPharm To Meet FDA Over Neomark
24 December 1997
Oncology Update In Brief
8 December 1997
Immunex' Generic Paclitaxel FDA Review
4 December 1997
Roche Files First NDA For Capecitabine
6 November 1997
Market Exclusivity Raise?Not This Year
29 October 1997
National And Multinational News In Brief From Japan
23 October 1997
Stock Comment New York
2 October 1997
New York Stock Comment
25 September 1997
Taxol Competitor From IVAX Nears US Market
25 September 1997
B-MS To Launch Taxol, Unreimbursed, In Japan
25 September 1997
Vertex, BioChem's MDR Drug Enters Phase II
18 September 1997
New Data With SB's Hycamtin In SCLC
22 August 1997
B-MS's Taxol Approved In Japan For Ovarian Cancer
24 July 1997
Galena To Produce New Anticancer Agent?
16 July 1997
World News In Brief: Taiwan
15 July 1997
New York Stock Comment
10 July 1997
Stock Commentary New York
3 July 1997
Amersham International And Nycomed To Merge
2 July 1997
Novartis Unveils Strong Product Pipeline
1 July 1997
Taxol Backed For KS
26 June 1997
Industry Slams Taiwan Over Alleged Drug Copying
26 June 1997
Generic Taxol
19 June 1997
B-MS In Czech Republic
30 May 1997
"Solid Growth" At Bristol-Myers Squibb
5 May 1997
First Launches For Yewtaxan Paclitaxel
9 April 1997
Vertex And BioChem Begin Ph II With VX-710
9 April 1997
IVAX And Teva On The Heels Of Taxol And Zovirax
7 April 1997
USA Urged To Withdraw Action Against Argentina
17 February 1997
UK Launch Of SmithKline Beecham's Hycamtin
17 February 1997
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
